Modified In-Office Superior Laryngeal Nerve Steroid Injection Technique for the Treatment of Chronic Cough
Journal of Clinical Medicine · 23.06.2026 · 15 (13) · 4883
DOI: 10.3390/jcm15134883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.06.2026. Verfasst von James Tsimiklis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head & Neck Surgery, Flinders Medical Centre, Adelaide 5042, Australia. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To compare an endoscopically guided, modified in-office internal superior laryngeal nerve (iSLN) percutaneous steroid injection technique with a traditional landmark-guided percutaneous approach for refractory chronic cough.
Methods
Single-centre retrospective comparative cohort study of those with chronic cough >8 weeks adjudicated as neurogenic/hypersensitivity-related after structured evaluation and management of common aetiologies. Consecutive patients treated at a tertiary laryngology service from January 2021 to January 2025 were identified. Patients underwent either landmark-guided percutaneous iSLN block (unmodified) or iSLN percutaneous block under flexible nasolaryngoscopic visualisation (modified), enabling real-time confirmation of needle position and routine bilateral treatment with partial superficial laryngeal mucosal instillation. Primary outcome was patient-reported improvement (Y/N; 1–10 severity scale). Secondary outcomes included Leicester Cough Questionnaire, Cough Severity Index, Newcastle Laryngeal Hypersensitivity Questionnaire, Reflux Severity Index, Voice Handicap Index-10, repeat procedures, and adverse events.
Results
Of 142 patients (median age 62.8 years; 75% female), 65 underwent landmark-guided injection and 77 underwent the modified endoscopically guided technique. At most recent follow-up, global improvement was reported by 84.4% (65/77) in the modified cohort versus 47.7% (31/65) in the unmodified cohort. Median symptom reduction was greater with the modified approach (77.8% (IQR 61.3–86.6)) than among unmodified responders (50.3% (IQR 25.0–75.0)). Across all validated patient-reported outcome measures, the modified technique demonstrated more pronounced improvement than the landmark-guided approach. Minor adverse events were uncommon (modified = 6.5%, unmodified = 4.6%).
Conclusions
Endoscopically guided modified iSLN steroid injection with routine bilateral targeting is associated with greater patient-reported improvement and superior validated cough outcomes than landmark-guided injection, without added significant risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head & Neck Surgery, Flinders Medical Centre, Adelaide 5042, Australia.
- Department of Otorhinolaryngology-Head & Neck Surgery, Flinders University, Adelaide 5042, Australia.
Zitieren
APA
Tsimiklis, J., & Athanasiadis, T. (2026). Modified In-Office Superior Laryngeal Nerve Steroid Injection Technique for the Treatment of Chronic Cough. Journal of Clinical Medicine, 15(13), 4883. https://doi.org/10.3390/jcm15134883
Vancouver
Tsimiklis J, Athanasiadis T. Modified In-Office Superior Laryngeal Nerve Steroid Injection Technique for the Treatment of Chronic Cough. Journal of Clinical Medicine. 2026;15(13):4883. doi:10.3390/jcm15134883
BibTeX
@article{Tsimiklis2026,
author = {Tsimiklis, James and Athanasiadis, Theodore},
title = {Modified In-Office Superior Laryngeal Nerve Steroid Injection Technique for the Treatment of Chronic Cough},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {4883},
doi = {10.3390/jcm15134883}
}
EUVIMED